Douglas, A., Thursky, K., Spelman, T., Szer, J., Bajel, A., Harrison, S., Tio, S. Y., Bupha-Intr, O., Tew, M., Worth, L., Teh, B., Chee, L., Ng, A., Carney, D., Khot, A., Haeusler, G., Yong, M., Trubiano, J., Chen, S., Hicks, R., Ritchie, D., & Slavin, M. (2022). [18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet, 9(8), e573–e584. http://access.bl.uk/ark:/81055/vdc_100159752727.0x000004